Welcome to BioPAD home, your biotechnology partner of choice. Our objective is to communicate basics of what BioPAD is all about and we trust the information will lead you to our real home at the Innovation Hub, Pretoria.
Saliva Can Help Diagnose Heart Attack, Study Shows
Early diagnosis of a heart attack may now be possible using only a few drops of saliva and a new nano-bio-chip, according to new research. The nano-bio-chip assay could some day be used to analyze ..
Source :www.sciencedaily.com
Darwin's private papers get Internet launch
The first draft of Charles Darwin's "On The Origin Of Species" is among a wealth of papers belonging to the intensely private man who changed science being published on the Internet on Thursday for the first time
Source :www.newsdaily.com/stories
Mining plants for anticancer drugs
Could SA plants hold the secret to a new cancer drug? Scientists in SA have identified 15 plants which they believe hold promise
Source : www.scienceinafrica.co.za
Highlights Archive
CLC bio tests Next Generation Sequencing solution on African tuberculosis data
World-class Wits team takes a cheeky look at pain relief
Forget the spoonful of sugar - an inspired group of innovators find axciting ways to get medicines right on target.
Have you taken your polymeric pill?
Pharmacologists at Wits University have launched a new drug delivery platform, taking advantage of advanced polymeric materials to create novel systems that are safe for human consumption.
Roche´s Genome Sequencer 20 Enters the African Continent: First System Installation at inqaba biotec’s Sequencing Facility in South Africa
Roche Applied Science, a business area of Roche Diagnostics, announced that they have sold the first ultrafast Genome Sequencer 20 System (including option for the new Genome Sequencer FLX) in Africa. South Africa's inqaba biotec will be the first user on the African continent.
BioPAD Bulletin May 2007
Welcome once more to the BioPAD world. As usual, we have exciting stories in store for you. But firstly, allow me to announce the entrance of BioPAD into a new era. The end of our financial year coincided with the departure of Mr Butana Mboniswa, CEO of BioPAD since its inception, and Mr Delon Mudaly, Portfolio Manager (Bioprocessing and Industrial Biotech). I would like to pay tribute to the exceptional contribution made by both Butana and Delon in building and shaping BioPAD into what it is today; I trust that they will continue to support BioPAD and our stakeholders in pursuit of buildinag a sustainable bioeconomy in the region.
Read More...
BioPAD Newsletter Vol 2 Issue 3
Bulletin Archive
US$40 million funding boost for African researchers
The UK-based medical charity the Wellcome Trust announced last week (11 April) that it would give £20 million (nearly US$40 million) towards training scientists in Sub-Saharan Africa.The focus will be on assisting young researchers who are completing or have recently completed their PhDs.
Source :www.scidev.net
Say goodbye to blood pressure?
A medical study has reportedly unveiled the answer to beating blood pressure.
Source :www.iol.co.za
